Sue Wall Street digs into the scams, cover-ups, and corporate faceplants that Wall Street hopes you’ll ignore. From fraud and insider trading to the whistleblowers who called it out we break down how the powerful play the game and sometimes get burned. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Go to ZLK.com for more on the case and follow us for the next corporate faceplant.
All content for SueWallSt is the property of SueWallSt and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Sue Wall Street digs into the scams, cover-ups, and corporate faceplants that Wall Street hopes you’ll ignore. From fraud and insider trading to the whistleblowers who called it out we break down how the powerful play the game and sometimes get burned. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Go to ZLK.com for more on the case and follow us for the next corporate faceplant.
$MLTX MoonLake Immunotherapeutics lost nearly 90% of its stock value in one day after clinical trial results for its flagship nanobody drug disappointed investors. In this episode of Sue Wall Street, we dissect the class action lawsuit accusing MoonLake of hyping unproven biotech claims and misleading the market. If you follow biotech stocks, clinical trial risk, or Wall Street spin, don’t miss this one.
Visit ZLK.com for more info.
Add our WhatsApp Channel.We’re not lawyers or accountants, so don’t take this as legal or financial advice.
SueWallSt
Sue Wall Street digs into the scams, cover-ups, and corporate faceplants that Wall Street hopes you’ll ignore. From fraud and insider trading to the whistleblowers who called it out we break down how the powerful play the game and sometimes get burned. We’re not lawyers or accountants, so don’t take this as legal or financial advice. Go to ZLK.com for more on the case and follow us for the next corporate faceplant.
